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Introduction 
Elephantiasis nostras verrucosa (ENV) is a debilitating 
and cosmetically disfiguring complication of chronic  
lymphedema [1, 2]. ENV commonly presents with 
diffusely scattered, verrucous, cobblestone-like 
papules, nodules, or plaques with nonpitting edema 
in the lower extremities; histopathology is marked by 
hyperkeratosis and dermal or subcutaneous fibrosis 
[1, 2]. Other locations that have also been reported 
include the upper extremities [3], ears [4], abdomen 
[5], back [6], sacrum [7], buttocks [7], and scrotum [8]. 
Reported risk factors include obesity, recurrent 
cellulitis or other soft-tissue infection, chronic 
venous insufficiency, surgery or other trauma, 
tumors, radiation, congestive heart failure, and 
scleroderma [1, 3]. We report an atypical case of ENV 
presenting with compressible cysts in the bilateral 
legs and thighs, with pitting edema extending to the 
thighs, that unusually persisted for 10 years after 
lymphoma remission. 
 
Case Synopsis 
A 72-year-old man presented to the dermatology 
clinic for an 11-year history of edematous legs, 
occasionally associated with ulcerations, with an 
insidious onset within a year of developing 
intrapelvic lymphoma. The patient reported feeling 
“very depressed” and physically disabled owing to 
his condition. He denied any pain, pruritus, fever, 
chills, weight loss, headache, nausea, vomiting, or 
international travel. Past medical history was 
significant for intrapelvic non-Hodgkin follicular B 
cell lymphoma status post-remission with 
chemotherapy, hypogammaglobulinemia, and 
morbid obesity. The patient did not have a history of 
lower extremity cellulitis. 
Abstract 
Elephantiasis nostras verrucosa is a progressively 
debilitating and disfiguring disease commonly 
presenting with verrucous, cobblestone-like papules, 
nodules, or plaques with nonpitting edema in the 
lower extremities. Histopathology is marked by 
hyperkeratosis and dermal or subcutaneous fibrosis 
as a result of chronic lymphedema. Risk factors 
include obesity, recurrent cellulitis, chronic venous 
insufficiency, congestive heart failure, scleroderma, 
radiation, trauma, and tumors. We report a 72-year-
old man who presented to the dermatology clinic for 
an 11-year history of edematous legs, occasionally 
associated with ulcerations. The findings developed 
within a year of intrapelvic non-Hodgkin lymphoma 
and progressed gradually over 10 years after 
lymphoma remission. Physical examination revealed 
atypical features including compressible cysts and 
pitting edema extending from the lower legs to the 
thighs bilaterally. The patient was noncompliant for 
the recommended compressive devices and the 
condition progressively worsened over the course of 
7 months of follow-up. Early interdisciplinary 
management using compressive devices and a 
lymphatic pump are recommended. Underlying 
causative factors should be assessed with regular 
follow-up to optimize treatment outcomes. 
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Physical examination revealed a verrucous, flesh-
colored-to-erythematous eruption consisting of 
compressible, weeping cysts and nodules of the 
bilateral legs and thighs associated with 2+ pitting 
edema extending to the thighs (Figure 1). No ulcers 
were observed at the time of examination. Leg 
circumference measured 30cm in bilateral ankles, 
47cm and 51cm at 15cm above the left and right 
ankles, respectively, and 49cm and 52.5cm in left and 
right calves, respectively. Capillary refill was 3-4 
seconds. Body mass index (BMI) was 37.45. 
Thyroid stimulating hormone was within normal 
limits. Serum IgG levels were significantly decreased 
at <200mg/dL. Complete metabolic panel was 
unremarkable for chronic kidney or liver disease. 
Echocardiogram was negative for heart failure. 
Venous duplex reflux studies displayed superficial 
cystic lesions consistent with lymphatic ectasia 
(Figure 2) bilaterally and evidence of superficial 
venous reflux with duration of 2.6-4.3 seconds 
involving the greater saphenous vein in the right 
lower leg only. 
A diagnosis of ENV was made. Differential diagnoses 
included venous stasis dermatitis, filariasis, pretibial 
myxedema, and lymphedema. The patient was 
advised to use triamcinolone ointment, 0.1%, 
customized Circaid compression device, and a 
lymphatic pump daily, although there is currently no 
standard guideline on frequency of lymphatic pump 
therapy. 
However, he was noncompliant for the 
recommended management as he reported 
difficulty with using the compressive device and 
lymphatic pump independently at home and 
considered the triamcinolone ointment to be too 
“greasy.” The lesions progressively worsened upon 
follow-up at one month, four months, and seven 
months (Figure 1C). Home health care visits were 
arranged to provide help with the compressive 
device and lymphatic pump at home in order to 
optimize management. 
 
Case Discussion 
According to a previously published retrospective 
analysis of 21 cases from 2006 to 2008, the most 
significant predisposing risk factors for ENV were 
obesity (100%) and cellulitis or other soft-tissue 
infection of the lower extremity (86%), [1]. The most 
likely precipitating factor for our patient’s initial 
onset was intrapelvic lymphoma obstructing the 
lymphatic channels. 
Figure 2. Ultrasound findings. Hypoechoic superficial cystic 
lesion (arrows) exhibited absence of flow using color Doppler.
   
 
Figure 1. (A-C). Clinical examination. Right A) and left B) lower 
extremities exhibited verrucous, flesh-colored to erythematous 
nodules and cysts (black arrows). Cysts were compressible upon 
manually applied pressure (blue arrows). C) Follow-up at four 
months of non-compliance to compressive devices or 
lymphedema pump revealed progression of cutaneous lesions.
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Interestingly, despite our patient’s remitted 
lymphoma, the patient continued to be affected by 
ENV bilaterally in the lower extremities. The 
persistence of the condition after remission of the 
tumor is highly unusual. Contributing factors to the 
persistent bilateral presentation may include 
increased hydrostatic pressure related to lymphatic 
obstruction by fibrosed intrapelvic lymph nodes 
following chemotherapy and biopsy, as well as 
decreased osmotic pressure related to 
hypogammaglobulinemia, promoting osmotic flow 
from the vasculature to the interstitium. The 
superficial venous reflux observed in the right lower 
leg may also indicate venous insufficiency as one 
contributory factor. Unlike most reported cases of 
ENV, the patient exhibited pitting edema and 
compressible cysts and nodules bilaterally. This 
unusual presentation could be a long-term 
consequence of chronic lymphatic ectasia extending 
to the superficial lymphatic channels concurrently 
with significantly altered osmotic pressures that 
worsen lymphatic flow mechanics, particularly in a 
patient noncompliant to recommended 
management with multiple risk factors (obesity, 
history of tumor, hypogammaglobulinemia, venous 
insufficiency). 
Application of a compressive device and lymphatic 
pump as initial therapy, along with early 
interdisciplinary management of underlying risk 
factors, is advised [1, 2] in order to prevent long-term 
sequelae including the severe, persistent edema and 
nodulocystic changes seen in our patient. Successful 
treatment with surgical excision [8, 9], 
lymphaticovenular anastomosis [10], systemic 
retinoids [11, 12], and ablative carbon dioxide laser 
[13] have also been reported in the literature. 
Limitations in patient compliance to recommended 
compression have hampered resolution in this case. 
 
Conclusion 
Elephantiasis nostras verrucosa is a progressively 
disfiguring disease commonly marked by extensive 
nonpitting edema and fibrotic papules, nodules, or 
plaques. Rarely, a patient may present with pitting 
edema and superficial, compressible cysts, as seen in 
our case. Furthermore, it is unusual for ENV 
associated with a tumor to persist after the tumor has 
been treated. 
Patients with physical or psychosocial disabilities 
may benefit from having a caregiver or regular home 
care visits arranged to increase compliance with the 
recommended treatment and prevent disease 
progression. Early interdisciplinary management 
using compressive devices and a lymphatic pump 
may be helpful. Addressing underlying causative 
factors, is strongly advised with regular follow-up to 
optimize treatment outcomes. 
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